/KLTOW

KLTOW Stock - Klotho Neurosciences, Inc.

Q: What is the analyst price target for KLTOW?

Analyst price target information is not currently available for KLTOW.

Q: What is KLTOW's market cap?

Market capitalization information is not currently available for KLTOW.

Healthcare|Biotechnology|NASDAQ

$0.10-17.09%

$0.02 (-17.09%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.11

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for KLTOW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.42

52W High$0.17

52W Low$0.10

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A
Operating Income	$-5,540,236	$-631,322	$-574,374	$-1,109,069
Net Income	$-6,150,372	$-707,458	$-598,593	$-1,109,025
Net Margin	N/A	N/A	N/A	N/A
EPS	$-0.32	$-0.04	$-0.03	$-0.06

Company Overview

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.

Visit Website

Frequently Asked Questions about KLTOW

What is KLTOW's current stock price?

Klotho Neurosciences, Inc. (KLTOW) is currently trading at $0.10 per share. The stock has moved -17.09% today.

What is the analyst price target for KLTOW?

No analyst price targets are currently available for this stock.

What sector is Klotho Neurosciences, Inc. in?

Klotho Neurosciences, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is KLTOW's market cap?

Klotho Neurosciences, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.

Does KLTOW pay dividends?

No, Klotho Neurosciences, Inc. does not currently pay a dividend to shareholders.